PFN4

gene
On this page

Summary

PFN4 (profilin family member 4, HGNC:31103) is a protein-coding gene on chromosome 2p23.3, encoding Profilin-4 (Q8NHR9). Involved in male fertility.

Predicted to enable actin monomer binding activity. Predicted to be involved in acrosome assembly; manchette assembly; and sperm flagellum assembly. Predicted to be located in cytoplasm. Predicted to be active in cell cortex.

Source: NCBI Gene 375189 — RefSeq curated summary.

At a glance

  • MANE Select transcript: NM_199346

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:31103
Approved symbolPFN4
Nameprofilin family member 4
Location2p23.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000176732
Ensembl biotypeprotein_coding
OMIM620046
Entrez375189

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 9 protein_coding, 1 protein_coding_CDS_not_defined

ENST00000313213, ENST00000436622, ENST00000465360, ENST00000897652, ENST00000897653, ENST00000897654, ENST00000897655, ENST00000897656, ENST00000897657, ENST00000897658

RefSeq mRNA: 1 — MANE Select: NM_199346 NM_199346

CCDS: CCDS1709

Canonical transcript exons

ENST00000313213 — 5 exons

ExonStartEnd
ENSE000012707302412311824123334
ENSE000012707382411480924115611
ENSE000012707482412241924122547
ENSE000035125832411957724119682
ENSE000036378152412116324121300

Expression profiles

Bgee: expression breadth ubiquitous, 161 present calls, max score 97.17.

FANTOM5 (CAGE): breadth broad, TPM avg 1.0045 / max 272.9064, expressed in 440 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
273160.4745214
273180.254845
273190.184746
273170.090613

Top tissues by expression

252 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453397.17gold quality
right testisUBERON:000453496.71gold quality
testisUBERON:000047394.78gold quality
spermCL:000001993.26gold quality
adult organismUBERON:000702390.94gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099190.24gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047389.39gold quality
pancreatic ductal cellCL:000207980.70silver quality
oviduct epitheliumUBERON:000480472.98gold quality
left ovaryUBERON:000211971.19gold quality
tibial nerveUBERON:000132370.47gold quality
lower esophagus mucosaUBERON:003583469.90gold quality
right ovaryUBERON:000211869.83gold quality
tibialis anteriorUBERON:000138569.77silver quality
buccal mucosa cellCL:000233669.55silver quality
right uterine tubeUBERON:000130269.08gold quality
adenohypophysisUBERON:000219668.63gold quality
popliteal arteryUBERON:000225068.57gold quality
tibial arteryUBERON:000761068.57gold quality
metanephros cortexUBERON:001053368.07gold quality
calcaneal tendonUBERON:000370167.74gold quality
cortical plateUBERON:000534367.15gold quality
ventricular zoneUBERON:000305366.97gold quality
pituitary glandUBERON:000000766.93gold quality
ovaryUBERON:000099266.90gold quality
ileal mucosaUBERON:000033166.85silver quality
olfactory segment of nasal mucosaUBERON:000538666.82gold quality
endocervixUBERON:000045866.64gold quality
right lobe of thyroid glandUBERON:000111966.47gold quality
aortaUBERON:000094766.46gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-GEOD-134144yes27.74
E-ANND-3no3.36

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

48 targeting PFN4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5692A100.0074.406850
HSA-MIR-6888-3P99.9765.951170
HSA-MIR-6778-3P99.9667.292693
HSA-MIR-335-3P99.9373.364958
HSA-MIR-145-5P99.9271.131836
HSA-MIR-5195-3P99.9270.921877
HSA-MIR-130599.9171.433443
HSA-MIR-129799.9173.413162
HSA-MIR-153-5P99.8973.866317
HSA-MIR-469899.8471.414303
HSA-MIR-4799-5P99.8270.602663
HSA-MIR-4659A-3P99.8072.624248
HSA-MIR-4659B-3P99.8072.624248
HSA-MIR-26A-5P99.7873.522303
HSA-MIR-431999.7669.832586
HSA-MIR-444199.4966.563216
HSA-MIR-125A-5P99.3670.591640
HSA-MIR-125B-5P99.3670.361662
HSA-MIR-324-3P99.2666.311034
HSA-MIR-3191-5P99.2466.521722
HSA-MIR-10399-5P99.1769.872610
HSA-MIR-6504-3P99.1769.312891
HSA-MIR-143-5P98.9868.87946
HSA-MIR-511-5P98.9770.942268
HSA-MIR-6770-5P98.9766.761853
HSA-MIR-219A-1-3P98.9167.87639
HSA-MIR-6871-5P98.9066.67671
HSA-MIR-4700-5P98.6367.431915
HSA-MIR-6830-3P98.6268.071760
HSA-MIR-126198.6268.10896

Literature-anchored findings (GeneRIF, showing 1)

  • Porfilin 4 bound to selected phosphoinositides but not to poly-L-proline, proline-rich proteins, or actin. (PMID:19419568)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriopfn4ENSDARG00000097487
mus_musculusPfn4ENSMUSG00000020639
rattus_norvegicusPfn4ENSRNOG00000050386
drosophila_melanogasterchicFBGN0000308
caenorhabditis_elegansWBGENE00003991

Protein

Protein identifiers

Profilin-4Q8NHR9 (reviewed: Q8NHR9)

Alternative names: Profilin IV

All UniProt accessions (2): Q8NHR9, A0A1D5RMN8

UniProt curated annotations — full annotation on UniProt →

Function. Involved in male fertility. Required for manchette development and acrosome biogenesis during spermiogenesis. Binds in vitro to phospholipids, including phosphatidylinositol 3-phosphate (PtdIns(3)P), phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2), phosphatidylinositol 4-phosphate (PtdIns(4)P) and phosphatidic acid (PA). Contrary to other profilin family members, does not bind to actin in vitro.

Subcellular location. Cytoplasm.

Tissue specificity. Expressed in testis, in germ cells in seminiferous tubules (at protein level). Prominently expressed in pachytene/diplotene stage spematocytes.

Similarity. Belongs to the profilin family.

RefSeq proteins (1): NP_955378* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR005455PFN_eukFamily
IPR036140PFN_sfHomologous_superfamily
IPR048278PFNFamily

Pfam: PF00235

UniProt features (1 total): chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NHR9-F194.160.84

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 62 (showing top): GOBP_VESICLE_ORGANIZATION, GOBP_MALE_GAMETE_GENERATION, GOBP_SECRETORY_GRANULE_ORGANIZATION, GOBP_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS, GOBP_CILIUM_ORGANIZATION, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_ACROSOME_ASSEMBLY, GOBP_ORGANELLE_ASSEMBLY, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOMF_ACTIN_BINDING, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MOTILE_CILIUM_ASSEMBLY, GOBP_CELL_PROJECTION_ORGANIZATION

GO Biological Process (6): acrosome assembly (GO:0001675), spermatogenesis (GO:0007283), flagellated sperm motility (GO:0030317), sperm flagellum assembly (GO:0120316), manchette assembly (GO:1905198), cell differentiation (GO:0030154)

GO Molecular Function (3): actin monomer binding (GO:0003785), lipid binding (GO:0008289), actin binding (GO:0003779)

GO Cellular Component (2): cell cortex (GO:0005938), cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
developmental process involved in reproduction3
spermatid development3
cellular component assembly involved in morphogenesis1
cellular process involved in reproduction in multicellular organism1
secretory granule organization1
organelle assembly1
male gamete generation1
cilium-dependent cell motility1
cilium movement involved in cell motility1
sperm motility1
flagellated sperm motility1
motile cilium assembly1
cellular component assembly1
cellular developmental process1
actin binding1
binding1
cytoskeletal protein binding1
cytoplasm1
cell periphery1
intracellular anatomical structure1
cellular anatomical structure1

Protein interactions and networks

STRING

2018 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PFN4VASPP50552998
PFN4ACTBP02570989
PFN4WASP42768984
PFN4GSNP06396960
PFN4CFL2Q9Y281958
PFN4CFL1P23528957
PFN4XPO6Q96QU8954
PFN4APBB1IPQ7Z5R6951
PFN4TMSB4XP01253934
PFN4WASLO00401919
PFN4SCINQ9Y6U3892
PFN4FMNL1O95466892
PFN4ACTR2P61160886
PFN4ACTG1P02571872
PFN4RAPH1Q70E73850

IntAct

3 interactions, top by confidence:

ABTypeScore
INSRBLTP3Bpsi-mi:“MI:0914”(association)0.350

ESM2 similar proteins: A4GCR5, A4GCR7, A4GCR8, A4GD50, A4GD54, A4GDQ8, A4GDR9, A4GDT3, A4GE38, A4GE39, A4KA54, A4KA61, A7RT29, A7S6M8, A9UMU8, D3ZVF4, P02584, P06625, P07737, P08240, P35080, P38334, P62962, P62963, Q08CN0, Q09430, Q0P3X8, Q0VGL1, Q29EZ6, Q29NZ8, Q2M2U3, Q2NKT1, Q3MHE8, Q4PM15, Q4R4P8, Q4S4I5, Q54DY3, Q54QW5, Q5IRJ7, Q5R483

Diamond homologs: A4GCR7, A4GD56, A4GDR8, A4GDT0, A4GE44, A4GFB7, A4GFB9, A4GFC2, A4GFC4, A4K9Z8, A4KA38, A4KA39, A4KA40, A4KA41, A4KA44, A4KA45, A4KA55, C6JWH0, O04725, O65812, P07274, P18322, P19984, P22271, P25816, P25843, P26199, P26200, P35081, P35083, P39825, P49230, P53696, P68696, P84177, Q21193, Q2NKT1, Q38905, Q42449, Q5IRJ7

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

0 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1087 predictions. Top by Δscore:

VariantEffectΔscore
2:24119575:A:ACdonor_gain1.0000
2:24119575:AC:Adonor_gain1.0000
2:24119576:C:CCdonor_gain1.0000
2:24119576:CC:Cdonor_gain1.0000
2:24119680:CTC:Cacceptor_gain1.0000
2:24119683:C:CCacceptor_gain1.0000
2:24121161:A:ACdonor_gain1.0000
2:24121162:C:CCdonor_gain1.0000
2:24122417:A:ACdonor_gain1.0000
2:24122418:C:CCdonor_gain1.0000
2:24123213:C:Adonor_gain1.0000
2:24123636:G:GTdonor_gain1.0000
2:24115609:CTCCT:Cacceptor_loss0.9900
2:24115612:CTGAA:Cacceptor_loss0.9900
2:24115613:T:Cacceptor_loss0.9900
2:24118676:G:Cacceptor_gain0.9900
2:24119570:AACTT:Adonor_loss0.9900
2:24119571:ACTT:Adonor_loss0.9900
2:24119572:CT:Cdonor_loss0.9900
2:24119573:TT:Tdonor_loss0.9900
2:24119574:TA:Tdonor_loss0.9900
2:24119575:A:AAdonor_loss0.9900
2:24119576:C:CTdonor_loss0.9900
2:24119678:TTCTC:Tacceptor_gain0.9900
2:24119679:TCTC:Tacceptor_gain0.9900
2:24119679:TCTCC:Tacceptor_loss0.9900
2:24119680:CTCC:Cacceptor_gain0.9900
2:24119681:TC:Tacceptor_gain0.9900
2:24119681:TCCT:Tacceptor_gain0.9900
2:24119682:CC:Cacceptor_gain0.9900

AlphaMissense

824 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:24119599:A:CC113W0.984
2:24119633:G:TA102E0.979
2:24122472:C:GA22P0.976
2:24121170:G:TA83D0.975
2:24121194:C:GR75P0.975
2:24119601:A:GC113R0.974
2:24122471:G:TA22D0.972
2:24122474:G:TA21E0.971
2:24119600:C:TC113Y0.970
2:24121171:C:GA83P0.967
2:24121192:C:GA76P0.967
2:24119592:C:GA116P0.966
2:24121176:A:GL81P0.965
2:24122483:A:TV18E0.965
2:24119663:A:TV92D0.962
2:24119634:C:GA102P0.961
2:24119666:A:TV91D0.960
2:24119642:A:GL99P0.958
2:24119672:C:TG89D0.957
2:24122468:A:GL23P0.956
2:24121201:A:GC73R0.955
2:24122475:C:GA21P0.952
2:24121262:A:CF52L0.951
2:24121262:A:TF52L0.951
2:24121264:A:GF52L0.951
2:24115602:A:GL124P0.949
2:24121221:A:GF66S0.945
2:24119605:G:CS111R0.944
2:24119605:G:TS111R0.944
2:24119607:T:GS111R0.944

dbSNP variants (sampled 300 via entrez): RS1000436993 (2:24120208 G>A), RS1001439737 (2:24118334 G>A), RS1001622513 (2:24118910 A>C,T), RS1002180794 (2:24117839 T>G), RS1002345727 (2:24124603 G>C), RS1002359544 (2:24120481 A>T), RS1002699816 (2:24124952 G>A), RS1002999815 (2:24117340 C>T), RS1003029061 (2:24122009 G>C), RS1003182111 (2:24116461 G>C), RS1003297352 (2:24123602 C>T), RS1003780134 (2:24116686 C>G,T), RS1003794072 (2:24123711 G>A,C,T), RS1003928709 (2:24116724 G>T), RS1004118024 (2:24123638 C>T)

Disease associations

OMIM: gene MIM:620046 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

15 total (human), top 15 by PubMed support.

ChemicalActions (top 5)PubMed papers
sotorasibaffects cotreatment, increases expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
4-aminophenylarsenoxideaffects binding, decreases reaction1
jinfukangaffects cotreatment, increases expression1
trametinibaffects cotreatment, increases expression1
NVP-BKM120affects cotreatment, increases expression1
Sunitinibdecreases expression1
Arsenic Trioxideaffects binding, decreases reaction1
Air Pollutantsincreases abundance, increases expression1
Arsenicincreases methylation1
Benzo(a)pyreneaffects methylation1
Cisplatinaffects cotreatment, increases expression1
Leaddecreases expression1
Cyclosporineincreases expression1
Particulate Matterincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.